Blake Borgeson
Director · 10 filings · Latest: Oct 6, 2026
RECURSION PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Borgeson Blake | — | Nov 12, 2024 | Proposed Sale | $7.64 | 11,447 | $87.5K | — | |
RXRX | Borgeson Blake | — | Oct 29, 2024 | Proposed Sale | $6.72 | 11,447 | $76.9K | — | |
RXRX | Borgeson Blake | — | Oct 15, 2024 | Proposed Sale | $6.67 | 11,447 | $76.3K | — | |
RXRX | Borgeson Blake | — | Oct 1, 2024 | Proposed Sale | $6.51 | 11,447 | $74.5K | — | |
RXRX | Borgeson Blake | — | Sep 17, 2024 | Proposed Sale | $6.84 | 11,447 | $78.3K | — | |
RXRX | Borgeson Blake | — | Sep 3, 2024 | Proposed Sale | $6.27 | 11,447 | $71.7K | — |
← Previous
Page 2 of 2